查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933308

全球肿瘤软体市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Medical Oncology Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 164 Pages | 商品交期: 请询问到货日

价格

肿瘤软体市场成长因子

由于全球癌症患者人数不断增加以及数位化医疗解决方案的广泛应用，全球肿瘤软体市场正经历稳步增长。 2025年市场规模估计为28.8亿美元，预计2026年将达到30.8亿美元。长期来看，预计在预测期内将以9.10%的复合年增长率成长，到2034年达到61.8亿美元。北美凭藉其先进的医疗基础设施和较高的癌症发生率，在2025年占全球市场41.00%的占有率。

肿瘤软体帮助医疗服务提供者管理全身性癌症治疗，包括化疗、免疫疗法、标靶治疗和荷尔蒙疗法。这些系统有助于简化患者资料管理、治疗计划、临床决策支援和副作用监测，从而提高整体治疗的准确性和效率。

市场驱动因素

全球癌症发生率的不断上升是关键的成长驱动因素之一。不断增长的患者群体对高效的患者记录管理和治疗计划解决方案产生了强劲的需求。 根据美国癌症协会的预测，到 2023 年，美国将新增约 196 万例癌症病例，凸显了肿瘤治疗系统面临的日益增长的压力。

另一个关键驱动因素是电子健康记录 (EHR) 和医疗保健数位化的快速普及。肿瘤软体与 EHR 的整合实现了对患者病史、检验报告和影像数据的无缝访问，从而提高了临床决策和工作流程效率。此外，对癌症监测和基于资讯学的解决方案的投资不断增加，也进一步加速了市场成长。

市场趋势

影响市场的关键趋势是利用基因组数据制定个人化的癌症治疗方案。肿瘤软体透过整合分析基因突变和生物标记的先进演算法，实现了精准医疗。这些工具可帮助肿瘤科医师选择标靶疗法，并根据患者的个别情况优化治疗方案。

由于其可扩展性、成本效益和易于数据整合，基于云端的肿瘤软体的使用也在迅速增长。预计到 2026 年，在云端基础设施日益普及和新产品发布的推动下，云端领域将占 54.55% 的市场占有率。

挑战与限制因素

儘管成长潜力巨大，但该市场仍面临网路安全风险和资料外洩带来的挑战。针对医疗保健系统的网路攻击日益增多，威胁着病患资料的机密性，并扰乱癌症治疗流程。例如，针对肿瘤软体供应商的勒索软体攻击先前曾导致治疗延误和营运中断，对患者信任度和软体采用率产生负面影响。

细分市场分析

依应用领域划分，患者记录管理以 54.87% 的市场占有率领先，这主要得益于医疗保健提供者之间对高效数据整合的需求。 由于对高效能、数据驱动型癌症治疗的需求不断增长，治疗计划和临床决策支援领域也呈现稳定成长。

依最终用户划分，医院和专科诊所占市场主导地位，市占率高达 74.03%。这得归功于肿瘤软体的广泛应用、完善的 IT 基础设施以及全球癌症治疗中心的扩张。

区域分析

预计到 2025 年，北美地区的市场收入将达到 11.8 亿美元，这主要得益于该地区较高的癌症发病率以及主要市场参与者的强大影响力。欧洲市场也呈现稳定成长，这主要得益于研究合作的加强和完善的数位基础设施。亚太地区预计将以最高的复合年增长率成长，这主要得益于癌症病例的增加、人口老化以及中国、日本和印度等国家不断扩大的数位肿瘤学举措。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家癌症盛行率（2023/2026）
  • 肿瘤软体的最新技术进展
  • 市场参与者的新产品发布
  • 关键趋势：併购、业务合作等
  • 新冠疫情的影响市场

第五章：全球肿瘤软体市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依部署方式划分
    • 云端部署
    • 本地部署
    • 混合部署
  • 市场分析、洞察与预测：依应用领域划分
    • 治疗计划
    • 病患记录管理
    • 临床决策支持
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和专科诊所
    • 诊断中心
    • 研究机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美肿瘤软体市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲肿瘤软体市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太肿瘤软体市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲肿瘤软体市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲肿瘤软体市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会（GCC）国家
    • 南亚非洲
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析(2026年)
  • 企业简介
    • Epic Systems Corporation
    • Altai, Inc.
    • Varian Medical Systems, Inc.(Siemens Healthineers AG)
    • Cerner Corporation(Oracle)
    • American Medical Software
    • Elekta
    • EndoSoft LLC
    • RaySearch Laboratories
    • MCKESSON CORPORATION
    • Koninklijke Philips N.V.
Product Code: FBI108933

Growth Factors of medical oncology software Market

The global medical oncology software market is witnessing steady growth due to the rising burden of cancer worldwide and the increasing adoption of digital healthcare solutions. In 2025, the market size stood at USD 2.88 billion and is expected to grow to USD 3.08 billion in 2026. Over the long term, the market is projected to reach USD 6.18 billion by 2034, expanding at a CAGR of 9.10% during the forecast period. North America dominated the global market with a 41.00% share in 2025, driven by advanced healthcare infrastructure and high cancer prevalence.

Medical oncology software supports healthcare providers in managing systemic cancer treatments such as chemotherapy, immunotherapy, targeted therapy, and hormone therapy. These systems help streamline patient data management, treatment planning, clinical decision support, and monitoring of adverse effects, improving overall treatment accuracy and efficiency.

Market Drivers

One of the primary growth drivers is the increasing incidence of cancer globally. The growing patient pool has created a strong demand for efficient patient record management and treatment planning solutions. According to the American Cancer Society, nearly 1.96 million new cancer cases were projected in the U.S. in 2023, highlighting the rising pressure on oncology care systems.

Another major driver is the rapid adoption of electronic health records (EHRs) and healthcare digitization. Integration of medical oncology software with EHRs enables seamless access to patient history, lab reports, and imaging data, improving clinical decision-making and workflow efficiency. Additionally, rising investments in cancer research and informatics-based solutions are further accelerating market growth.

Market Trends

A key trend shaping the market is the development of personalized cancer treatment plans using genomic data. Medical oncology software increasingly incorporates advanced algorithms to analyze genetic mutations and biomarkers, enabling precision medicine. These tools assist oncologists in selecting targeted therapies and optimizing treatment regimens based on individual patient profiles.

The use of cloud-based oncology software is also expanding rapidly due to scalability, cost efficiency, and easier data integration. In 2026, the cloud segment accounted for 54.55% of the market share, supported by rising cloud infrastructure adoption and new product launches.

Challenges and Restraints

Despite strong growth potential, the market faces challenges related to cybersecurity risks and data breaches. Increasing cyberattacks on healthcare systems threaten patient data confidentiality and can disrupt cancer treatment workflows. For instance, ransomware attacks on oncology software providers have previously led to treatment delays and operational disruptions, negatively impacting patient trust and software adoption.

Segmentation Insights

By application, patient record management dominated the market with a 54.87% share, driven by the need for streamlined data coordination among healthcare providers. Treatment planning and clinical decision support segments are also growing steadily due to increasing demand for efficient and data-driven oncology care.

By end-user, hospitals and specialty clinics led the market with a 74.03% share, supported by widespread adoption of oncology software, established IT infrastructure, and the expansion of cancer care centers worldwide.

Regional Analysis

North America generated USD 1.18 billion in revenue in 2025, supported by high cancer prevalence and strong presence of leading market players. Europe followed with steady growth due to increasing research collaborations and digital infrastructure development. The Asia Pacific region is expected to grow at the fastest CAGR, driven by rising cancer cases, aging populations, and expanding digital oncology initiatives in countries such as China, Japan, and India.

Competitive Landscape

The market is highly consolidated, with key players such as Varian Medical Systems (Siemens Healthineers), Elekta, Epic Systems Corporation, Oracle (Cerner), and Philips holding significant shares. Strategic partnerships, acquisitions, and innovation-driven product launches continue to strengthen their global market presence.

Conclusion

The global medical oncology software market is set for sustained expansion, driven by rising cancer prevalence, increasing adoption of EHR-integrated solutions, and advancements in precision medicine. With the market growing from USD 2.88 billion in 2025 to USD 6.18 billion by 2034, medical oncology software is becoming a critical component of modern cancer care. Continued investments in cloud-based platforms, genomic integration, and data security will play a pivotal role in shaping the future of oncology informatics during the forecast period.

Segmentation By Deployment Type

  • Clouds
  • On-premise
  • Hybrid

By Application

  • Treatment Planning
  • Patient Record Management
  • Clinical Decision Support
  • Others

By End User

  • Hospitals & Specialty Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others

By Region

  • North America (By Deployment Type, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Deployment Type, Application, End-user, and Country/sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Deployment Type, Application, End-user, and Country/sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Deployment Type, Application, and End-user)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Deployment Type, Application, and End-user)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Cancer, by Key Countries, in 2023/2026
  • 4.2. Recent Technological Advancements in Medical Oncology Software
  • 4.3. New Product Launches by Market Players
  • 4.4. Key Industry Developments - Mergers, Acquisitions, Partnerships
  • 4.5. Impact of COVID-19 on the Market

5. Global Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 5.1.1. Clouds
    • 5.1.2. On-premise
    • 5.1.3. Hybrid
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Treatment Planning
    • 5.2.2. Patient Record Management
    • 5.2.3. Clinical Decision Support
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & Specialty Clinics
    • 5.3.2. Diagnostic Centers
    • 5.3.3. Research Institutes
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 6.1.1. Clouds
    • 6.1.2. On-premise
    • 6.1.3. Hybrid
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Treatment Planning
    • 6.2.2. Patient Record Management
    • 6.2.3. Clinical Decision Support
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & Specialty Clinics
    • 6.3.2. Diagnostic Centers
    • 6.3.3. Research Institutes
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 7.1.1. Clouds
    • 7.1.2. On-premise
    • 7.1.3. Hybrid
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Treatment Planning
    • 7.2.2. Patient Record Management
    • 7.2.3. Clinical Decision Support
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & Specialty Clinics
    • 7.3.2. Diagnostic Centers
    • 7.3.3. Research Institutes
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 8.1.1. Clouds
    • 8.1.2. On-premise
    • 8.1.3. Hybrid
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Treatment Planning
    • 8.2.2. Patient Record Management
    • 8.2.3. Clinical Decision Support
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & Specialty Clinics
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Research Institutes
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 9.1.1. Clouds
    • 9.1.2. On-premise
    • 9.1.3. Hybrid
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Treatment Planning
    • 9.2.2. Patient Record Management
    • 9.2.3. Clinical Decision Support
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & Specialty Clinics
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Research Institutes
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Medical Oncology Software Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Deployment Type
    • 10.1.1. Clouds
    • 10.1.2. On-premise
    • 10.1.3. Hybrid
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Treatment Planning
    • 10.2.2. Patient Record Management
    • 10.2.3. Clinical Decision Support
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & Specialty Clinics
    • 10.3.2. Diagnostic Centers
    • 10.3.3. Research Institutes
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2026)
  • 11.2. Company Profiles
    • 11.2.1. Epic Systems Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Altai, Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Varian Medical Systems, Inc. (Siemens Healthineers AG)
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Cerner Corporation (Oracle)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. American Medical Software
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Elekta
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. EndoSoft LLC
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. RaySearch Laboratories
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. MCKESSON CORPORATION
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Koninklijke Philips N.V.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 02: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 03: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 04: Global Medical Oncology Software Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 05: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 06: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 07: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 08: North America Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 09: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 10: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: Europe Medical Oncology Software Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 13: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 14: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 15: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 16: Asia Pacific Medical Oncology Software Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 17: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 18: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Latin America Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 21: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Deployment Type, 2021-2034
  • Table 22: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 24: Middle East & Africa Medical Oncology Software Market Revenue (USD billion) Forecast, By Country, 2021-2034

List of Figures

  • Figure 01: Global Medical Oncology Software Market Revenue Breakdown (USD billion, %) by Region, 2026 & 2034
  • Figure 02: Global Medical Oncology Software Market Value Share (%), By Deployment Type, 2026 & 2034
  • Figure 03: Global Medical Oncology Software Market Value Share (%), By Application, 2026 & 2034
  • Figure 04: Global Medical Oncology Software Market Value Share (%), By End User, 2026 & 2034
  • Figure 05: Global Medical Oncology Software Market Value Share (%), By Region, 2026 & 2034
  • Figure 06: North America Medical Oncology Software Market Value (USD billion), by Deployment Type, 2026 & 2034
  • Figure 07: North America Medical Oncology Software Market Value Share (%), by Deployment Type, 2026
  • Figure 08: North America Medical Oncology Software Market Value (USD billion), by Application, 2026 & 2034
  • Figure 09: North America Medical Oncology Software Market Value Share (%), by Application, 2026
  • Figure 10: North America Medical Oncology Software Market Value (USD billion), by End User, 2026 & 2034
  • Figure 11: North America Medical Oncology Software Market Value Share (%), by End User, 2026
  • Figure 12: North America Medical Oncology Software Market Value (USD billion), by Country, 2026 & 2034
  • Figure 13: North America Medical Oncology Software Market Value Share (%), by Country, 2026
  • Figure 14: Europe Medical Oncology Software Market Value (USD billion), by Deployment Type, 2026 & 2034
  • Figure 15: Europe Medical Oncology Software Market Value Share (%), by Deployment Type, 2026
  • Figure 16: Europe Medical Oncology Software Market Value (USD billion), by Application, 2026 & 2034
  • Figure 17: Europe Medical Oncology Software Market Value Share (%), by Application, 2026
  • Figure 18: Europe Medical Oncology Software Market Value (USD billion), by End User, 2026 & 2034
  • Figure 19: Europe Medical Oncology Software Market Value Share (%), by End User, 2026
  • Figure 20: Europe Medical Oncology Software Market Value (USD billion), by Country/Sub-Region, 2026 & 2034
  • Figure 21: Europe Medical Oncology Software Market Value Share (%), by Country/Sub-Region, 2026
  • Figure 22: Asia Pacific Medical Oncology Software Market Value (USD billion), by Deployment Type, 2026 & 2034
  • Figure 23: Asia Pacific Medical Oncology Software Market Value Share (%), by Deployment Type, 2026
  • Figure 24: Asia Pacific Medical Oncology Software Market Value (USD billion), by Application, 2026 & 2034
  • Figure 25: Asia Pacific Medical Oncology Software Market Value Share (%), by Application, 2026
  • Figure 26: Asia Pacific Medical Oncology Software Market Value (USD billion), by End User, 2026 & 2034
  • Figure 27: Asia Pacific Medical Oncology Software Market Value Share (%), by End User, 2026
  • Figure 28: Asia Pacific Medical Oncology Software Market Value (USD billion), by Country/Sub-Region, 2026 & 2034
  • Figure 29: Asia Pacific Medical Oncology Software Market Value Share (%), by Country/Sub-Region, 2026
  • Figure 30: Latin America Medical Oncology Software Market Value (USD billion), by Deployment Type, 2026 & 2034
  • Figure 31: Latin America Medical Oncology Software Market Value Share (%), by Deployment Type, 2026
  • Figure 32: Latin America Medical Oncology Software Market Value (USD billion), by Application, 2026 & 2034
  • Figure 33: Latin America Medical Oncology Software Market Value Share (%), by Application, 2026
  • Figure 34: Latin America Medical Oncology Software Market Value (USD billion), by End User, 2026 & 2034
  • Figure 35: Latin America Medical Oncology Software Market Value Share (%), by End User, 2026
  • Figure 36: Latin America Medical Oncology Software Market Value (USD billion), by Country, 2026 & 2034
  • Figure 37: Latin America Medical Oncology Software Market Value Share (%), by Country, 2026
  • Figure 38: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Deployment Type, 2026 & 2034
  • Figure 39: Middle East & Africa Medical Oncology Software Market Value Share (%), by Deployment Type, 2026
  • Figure 40: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Application, 2026 & 2034
  • Figure 41: Middle East & Africa Medical Oncology Software Market Value Share (%), by Application, 2026
  • Figure 42: Middle East & Africa Medical Oncology Software Market Value (USD billion), by End User, 2026 & 2034
  • Figure 43: Middle East & Africa Medical Oncology Software Market Value Share (%), by End User, 2026
  • Figure 44: Middle East & Africa Medical Oncology Software Market Value (USD billion), by Country, 2026 & 2034
  • Figure 45: Middle East & Africa Medical Oncology Software Market Value Share (%), by Country, 2026
  • Figure 46: Global Medical Oncology Software Market Share Analysis, By Company, 2026